Jade Biosciences (JBIO) Research & Development (2020 - 2026)

Jade Biosciences has reported Research & Development for 7 years, with the latest figure at $36.1 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 80.06% year-over-year to $36.1 million; the trailing twelve-month figure through Mar 2026 stood at $82.1 million (up 26.49% YoY), and the FY2025 full-year result was $93.1 million, up 75.08% from the prior year.
• Research & Development for Q1 2026 stood at $36.1 million, up from $1.5 million in the prior quarter.
• The five-year high for Research & Development was $36.1 million in Q1 2026, with the low at $78000.0 in Q2 2024.
• Historically, Research & Development has averaged $15.9 million across 5 years, with a median of $16.0 million in 2023.
• Annual changes were most pronounced in 2024 — Research & Development tumbled 99.51% — and 2025, when it surged 28806.41%.
• Jade Biosciences' Research & Development stood at $12.2 million in 2022, then surged by 45.76% to $17.8 million in 2023, then jumped by 75.34% to $31.2 million in 2024, then slumped by 95.2% to $1.5 million in 2025, then surged by 2303.53% to $36.1 million in 2026.
• The last three Research & Development figures came in at $36.1 million (Q1 2026), $1.5 million (Q4 2025), and $22.0 million (Q3 2025), per Business Quant data.